Roberto Giovannoni
Overview
Explore the profile of Roberto Giovannoni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
937
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tempora P, DAmico S, Gragera P, Damiani V, Krol K, Scaldaferri V, et al.
J Exp Clin Cancer Res
. 2024 Oct;
43(1):292.
PMID: 39438988
Background: Checkpoint immunotherapy unleashes tumor control by T cells, but it is undermined in non-immunogenic tumors, e.g. with low MHC class I expression and low neoantigen burden, such as neuroblastoma...
2.
Narra F, Piragine E, Benedetti G, Ceccanti C, Florio M, Spezzini J, et al.
Compr Rev Food Sci Food Saf
. 2024 Aug;
23(6):e13426.
PMID: 39169551
Bioactive compounds in fruit and vegetables have a positive impact on human health by reducing oxidative stress, inflammation, and the risk of chronic diseases such as cancer, cardiovascular (CV) diseases,...
3.
Costagli S, Abenaim L, Rosini G, Conti B, Giovannoni R
Insects
. 2024 Feb;
15(2).
PMID: 38392552
is a species of great interest for numerous industrial applications. A high-quality reference genome is already available for . However, the worldwide maintenance of numerous captive populations of , each...
4.
Strategies for single base gene editing in an immortalized human cell line by CRISPR/Cas9 technology
Corrado A, Aceto R, Miglietta S, Silvestri R, DellAnno I, Lepori I, et al.
3 Biotech
. 2024 Jan;
14(2):45.
PMID: 38261961
Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-023-03878-4.
5.
Mierzejewska P, Di Marzo N, Zabielska-Kaczorowska M, Walczak I, Slominska E, Lavitrano M, et al.
Pharmaceuticals (Basel)
. 2023 Oct;
16(10).
PMID: 37895880
The vascular endothelium is key target for immune and thrombotic responses that has to be controlled in successful xenotransplantation. Several genes were identified that, if induced or overexpressed, help to...
6.
Vitulo M, Gnodi E, Rosini G, Meneveri R, Giovannoni R, Barisani D
Int J Mol Sci
. 2023 Aug;
24(16).
PMID: 37628929
Nonalcoholic fatty liver disease (NAFLD, including nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH)) is a high-prevalence disorder, affecting about 1 billion people, which can evolve to more severe conditions...
7.
Cifaldi L, Melaiu O, Giovannoni R, Benvenuto M, Focaccetti C, Nardozi D, et al.
Front Immunol
. 2023 Jun;
14:1197053.
PMID: 37359555
DNAM-1 is a major NK cell activating receptor and, together with NKG2D and NCRs, by binding specific ligands, strongly contributes to mediating the killing of tumor or virus-infected cells. DNAM-1...
8.
Virtuoso A, De Luca C, Cirillo G, Riva M, Romano G, Bentivegna A, et al.
Mol Neurobiol
. 2022 Sep;
59(11):6857-6873.
PMID: 36048342
Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor with a malignant prognosis. GBM is characterized by high cellular heterogeneity and its progression relies on the interaction with the...
9.
Kutryb-Zajac B, Kawecka A, Braczko A, Franczak M, Slominska E, Giovannoni R, et al.
Biomedicines
. 2022 Jul;
10(7).
PMID: 35884844
Chronic hypoxia drives vascular dysfunction by various mechanisms, including changes in mitochondrial respiration. Although endothelial cells (ECs) rely predominantly on glycolysis, hypoxia is known to alter oxidative phosphorylation, promote oxidative...
10.
Torsello B, De Marco S, Bombelli S, Chisci E, Cassina V, Corti R, et al.
Biol Open
. 2021 Jun;
10(5).
PMID: 34184728
No abstract available.